(1->4)-beta-D-glucan multiple interactions ISO RGD:734097 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of LPAR3 mRNA CTD PMID:36331819 1,1-dichloroethene decreases expression ISO RGD:734097 6480464 vinylidene chloride results in decreased expression of LPAR3 mRNA CTD PMID:26682919 1,2-dimethylhydrazine multiple interactions EXP 6480464 [APC protein affects the susceptibility to 1, 2-Dimethylhydrazine] which results in increased expression of LPAR3 mRNA CTD PMID:27840820 1-octadec-9-enoylglycero-3-phosphate multiple interactions ISO RGD:1323219 6480464 Endocannabinoids inhibits the reaction [lysophosphatidic acid binds to and results in increased activity of LPAR3 protein], lysophosphatidic acid binds to and results in increased activity of LPAR3 protein CTD PMID:30102254 17beta-estradiol multiple interactions ISO RGD:1323219 6480464 [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in increased expression of LPAR3 mRNA CTD PMID:20823114 17beta-hydroxy-5alpha-androstan-3-one increases expression ISO RGD:1323219 6480464 Dihydrotestosterone results in increased expression of LPAR3 mRNA CTD PMID:29581250 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of LPAR3 mRNA CTD PMID:22298810 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:734097 6480464 Tetrachlorodibenzodioxin affects the expression of LPAR3 mRNA CTD PMID:21570461 2-hydroxypropanoic acid decreases expression ISO RGD:1323219 6480464 Lactic Acid results in decreased expression of LPAR3 mRNA CTD PMID:30851411 3-chloropropane-1,2-diol increases expression EXP 6480464 alpha-Chlorohydrin results in increased expression of LPAR3 mRNA CTD PMID:28522335 4,4'-sulfonyldiphenol decreases methylation ISO RGD:734097 6480464 bis(4-hydroxyphenyl)sulfone results in decreased methylation of LPAR3 exon CTD PMID:33297965 4-nonylphenol increases expression EXP 6480464 4-nonylphenol results in increased expression of LPAR3 mRNA CTD PMID:24460192 aflatoxin B1 decreases expression ISO RGD:1323219 6480464 Aflatoxin B1 results in decreased expression of LPAR3 mRNA CTD PMID:22100608 aflatoxin B1 decreases methylation ISO RGD:1323219 6480464 Aflatoxin B1 results in decreased methylation of LPAR3 gene CTD PMID:27153756 all-trans-retinoic acid increases expression EXP 6480464 Tretinoin results in increased expression of LPAR3 mRNA CTD PMID:20488242 all-trans-retinoic acid decreases expression ISO RGD:1323219 6480464 Tretinoin results in decreased expression of LPAR3 mRNA CTD PMID:21934132 , PMID:23724009 allethrin multiple interactions EXP 6480464 [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of LPAR3 protein CTD PMID:34896426 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of LPAR3 mRNA CTD PMID:16483693 arsane affects methylation ISO RGD:1323219 6480464 Arsenic affects the methylation of LPAR3 gene CTD PMID:25304211 arsenic atom affects methylation ISO RGD:1323219 6480464 Arsenic affects the methylation of LPAR3 gene CTD PMID:25304211 atrazine affects methylation EXP 6480464 Atrazine affects the methylation of LPAR3 gene CTD PMID:28931070 , PMID:35440735 benzo[a]pyrene increases methylation ISO RGD:734097 6480464 Benzo(a)pyrene results in increased methylation of LPAR3 intron CTD PMID:27901495 benzo[a]pyrene increases methylation ISO RGD:1323219 6480464 Benzo(a)pyrene results in increased methylation of LPAR3 5' UTR, Benzo(a)pyrene results in increased methylation of LPAR3 promoter CTD PMID:27901495 benzo[a]pyrene affects methylation ISO RGD:1323219 6480464 Benzo(a)pyrene affects the methylation of LPAR3 intron CTD PMID:30157460 bisphenol A decreases expression ISO RGD:1323219 6480464 bisphenol A results in decreased expression of LPAR3 mRNA CTD PMID:20678512 bisphenol A increases expression ISO RGD:734097 6480464 bisphenol A results in increased expression of LPAR3 mRNA CTD PMID:32156529 bisphenol A decreases methylation ISO RGD:734097 6480464 bisphenol A results in decreased methylation of LPAR3 promoter CTD PMID:27312807 bisphenol A increases methylation EXP 6480464 bisphenol A results in increased methylation of LPAR3 gene CTD PMID:28505145 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of LPAR3 mRNA CTD PMID:24460192 more ... bromobenzene increases expression EXP 6480464 bromobenzene results in increased expression of LPAR3 mRNA CTD PMID:32479839 bucladesine multiple interactions ISO RGD:1323219 6480464 [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in increased expression of LPAR3 mRNA CTD PMID:20823114 cadmium atom multiple interactions ISO RGD:1323219 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of LPAR3 mRNA CTD PMID:35301059 cadmium dichloride multiple interactions ISO RGD:1323219 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of LPAR3 mRNA CTD PMID:35301059 carbon nanotube affects expression ISO RGD:734097 6480464 Nanotubes, Carbon analog affects the expression of LPAR3 mRNA CTD PMID:25554681 carbon nanotube decreases expression ISO RGD:734097 6480464 Nanotubes, Carbon results in decreased expression of LPAR3 mRNA CTD PMID:25554681 CGP 52608 multiple interactions ISO RGD:1323219 6480464 CGP 52608 promotes the reaction [RORA protein binds to LPAR3 gene] CTD PMID:28238834 chlordecone decreases expression ISO RGD:734097 6480464 Chlordecone results in decreased expression of LPAR3 mRNA CTD PMID:33711761 chromium(6+) affects expression ISO RGD:734097 6480464 chromium hexavalent ion affects the expression of LPAR3 mRNA CTD PMID:28472532 cyhalothrin multiple interactions EXP 6480464 [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of LPAR3 protein CTD PMID:34896426 cypermethrin multiple interactions EXP 6480464 [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of LPAR3 protein CTD PMID:34896426 decabromodiphenyl ether increases expression EXP 6480464 decabromobiphenyl ether results in increased expression of LPAR3 mRNA CTD PMID:23914054 dextran sulfate multiple interactions ISO RGD:734097 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of LPAR3 mRNA CTD PMID:29950665 dioxygen multiple interactions ISO RGD:734097 6480464 [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of LPAR3 mRNA CTD PMID:30529165 dorsomorphin multiple interactions ISO RGD:1323219 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 endosulfan affects expression EXP 6480464 Endosulfan affects the expression of LPAR3 mRNA CTD PMID:29391264 entinostat increases expression ISO RGD:1323219 6480464 entinostat results in increased expression of LPAR3 mRNA CTD PMID:26272509 , PMID:27188386 entinostat multiple interactions ISO RGD:1323219 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LPAR3 mRNA CTD PMID:27188386 fenvalerate multiple interactions EXP 6480464 [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of LPAR3 protein CTD PMID:34896426 flusilazole increases expression EXP 6480464 flusilazole results in increased expression of LPAR3 mRNA CTD PMID:28263823 furan decreases expression EXP 6480464 furan results in decreased expression of LPAR3 mRNA CTD PMID:26194646 glyphosate increases methylation EXP 6480464 glyphosate results in increased methylation of LPAR3 gene CTD PMID:31011160 glyphosate increases expression ISO RGD:1323219 6480464 glyphosate results in increased expression of LPAR3 mRNA CTD PMID:31295307 glyphosate decreases expression ISO RGD:1323219 6480464 glyphosate results in decreased expression of LPAR3 mRNA CTD PMID:31295307 GW 4064 increases expression ISO RGD:734097 6480464 GW 4064 results in increased expression of LPAR3 mRNA CTD PMID:26655953 lipopolysaccharide increases expression ISO RGD:734097 6480464 Lipopolysaccharides results in increased expression of LPAR3 protein CTD PMID:21821728 medroxyprogesterone acetate multiple interactions ISO RGD:1323219 6480464 [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in increased expression of LPAR3 mRNA CTD PMID:20823114 mercury dibromide decreases expression ISO RGD:1323219 6480464 mercuric bromide results in decreased expression of LPAR3 mRNA CTD PMID:26272509 mercury dibromide multiple interactions ISO RGD:1323219 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of LPAR3 mRNA CTD PMID:27188386 metformin decreases expression EXP 6480464 Metformin results in decreased expression of LPAR3 mRNA CTD PMID:31324951 mifepristone multiple interactions ISO RGD:734097 6480464 Mifepristone inhibits the reaction [Progesterone results in increased expression of LPAR3 mRNA] CTD PMID:16815476 mifepristone decreases expression ISO RGD:734097 6480464 Mifepristone results in decreased expression of LPAR3 mRNA CTD PMID:16815476 N-ethyl-N-nitrosourea increases mutagenesis ISO RGD:734097 6480464 Ethylnitrosourea results in increased mutagenesis of LPAR3 mRNA CTD PMID:27776689 nickel sulfate increases expression ISO RGD:1323219 6480464 nickel sulfate results in increased expression of LPAR3 mRNA CTD PMID:22714537 Nor-9-carboxy-delta9-THC multiple interactions ISO RGD:1323219 6480464 [Cannabinoids results in increased abundance of 11-nor-delta(9)-tetrahydrocannabinol-9-carboxylic acid] which affects the methylation of LPAR3 gene CTD PMID:30521419 paracetamol decreases expression ISO RGD:1323219 6480464 Acetaminophen results in decreased expression of LPAR3 mRNA CTD PMID:26690555 paraquat decreases expression EXP 6480464 Paraquat results in decreased expression of LPAR3 mRNA CTD PMID:32680482 perfluorooctane-1-sulfonic acid multiple interactions ISO RGD:734097 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of LPAR3 mRNA CTD PMID:36331819 phenylmercury acetate decreases expression ISO RGD:1323219 6480464 Phenylmercuric Acetate results in decreased expression of LPAR3 mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO RGD:1323219 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of LPAR3 mRNA CTD PMID:27188386 potassium chromate increases expression ISO RGD:1323219 6480464 potassium chromate(VI) results in increased expression of LPAR3 mRNA CTD PMID:22714537 progesterone increases expression ISO RGD:1323219 6480464 Progesterone results in increased expression of LPAR3 mRNA CTD PMID:17404688 progesterone increases expression ISO RGD:734097 6480464 Progesterone results in increased expression of LPAR3 mRNA CTD PMID:16815476 progesterone multiple interactions ISO RGD:734097 6480464 Estrogens inhibits the reaction [Progesterone results in increased expression of LPAR3 mRNA], Mifepristone inhibits the reaction [Progesterone results in increased expression of LPAR3 mRNA] CTD PMID:16815476 pyrethrins decreases expression EXP 6480464 Pyrethrins results in decreased expression of LPAR3 protein CTD PMID:34896426 quercitrin increases expression ISO RGD:1323219 6480464 quercitrin results in increased expression of LPAR3 mRNA CTD PMID:25193878 rac-lactic acid decreases expression ISO RGD:1323219 6480464 Lactic Acid results in decreased expression of LPAR3 mRNA CTD PMID:30851411 rotenone increases expression EXP 6480464 Rotenone results in increased expression of LPAR3 mRNA CTD PMID:28374803 SB 431542 multiple interactions ISO RGD:1323219 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 sodium arsenite increases expression ISO RGD:1323219 6480464 sodium arsenite results in increased expression of LPAR3 mRNA CTD PMID:22714537 , PMID:34032870 sodium arsenite affects methylation ISO RGD:1323219 6480464 sodium arsenite affects the methylation of LPAR3 gene CTD PMID:28589171 sunitinib decreases expression ISO RGD:1323219 6480464 Sunitinib results in decreased expression of LPAR3 mRNA CTD PMID:31533062 thioacetamide decreases expression EXP 6480464 Thioacetamide results in decreased expression of LPAR3 mRNA CTD PMID:34492290 titanium dioxide decreases expression ISO RGD:734097 6480464 titanium dioxide results in decreased expression of LPAR3 mRNA CTD PMID:23409001 , PMID:29264374 titanium dioxide multiple interactions ISO RGD:734097 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of LPAR3 mRNA CTD PMID:29950665 trichloroethene decreases expression EXP 6480464 Trichloroethylene results in decreased expression of LPAR3 mRNA CTD PMID:33387578 trichostatin A increases expression ISO RGD:1323219 6480464 trichostatin A results in increased expression of LPAR3 mRNA CTD PMID:24935251 , PMID:26272509 trichostatin A multiple interactions ISO RGD:1323219 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LPAR3 mRNA CTD PMID:27188386 triclosan decreases expression ISO RGD:1323219 6480464 Triclosan results in decreased expression of LPAR3 mRNA CTD PMID:30510588 valproic acid increases expression ISO RGD:1323219 6480464 Valproic Acid results in increased expression of LPAR3 mRNA CTD PMID:23179753 more ... valproic acid decreases expression EXP 6480464 Valproic Acid results in decreased expression of LPAR3 mRNA CTD PMID:35594946 valproic acid multiple interactions ISO RGD:1323219 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LPAR3 mRNA CTD PMID:27188386 vancomycin increases expression ISO RGD:734097 6480464 Vancomycin results in increased expression of LPAR3 mRNA CTD PMID:18930951 vinclozolin decreases expression EXP 6480464 vinclozolin results in decreased expression of LPAR3 mRNA CTD PMID:23034163 vinclozolin increases methylation EXP 6480464 vinclozolin results in increased methylation of LPAR3 gene CTD PMID:31682807 vorinostat increases expression ISO RGD:1323219 6480464 vorinostat results in increased expression of LPAR3 mRNA CTD PMID:27188386